![]() |
市場調查報告書
商品編碼
1941657
2026-2034年按設備類型、最終用戶、分銷管道和地區分類的自我護理醫療設備市場規模、佔有率、趨勢和預測Self-Care Medical Devices Market Size, Share, Trends and Forecast by Device Type, End-User, Distribution Channel, and Region, 2026-2034 |
||||||
全球自我護理醫療設備市場預計到2025年將達到275億美元。展望未來,IMARC Group預測,到2034年該市場規模將達到450億美元,2026年至2034年的複合年成長率(CAGR)為5.65%。北美目前主導,預計2025年將佔據超過34.7%的市場。人口老化以及糖尿病和高血壓等慢性疾病盛行率的上升正在推動對自我護理醫療設備的需求。人工智慧平台、穿戴式裝置和非侵入式監測技術等技術進步進一步提高了設備的普及率和功能性。各公司正在開發創新產品並建立合作夥伴關係以保持競爭力,從而進一步推動自我護理醫療設備市場的成長。
隨著醫療成本的不斷上漲,自我護理醫療設備為患者提供了經濟有效的解決方案。它們是管理慢性病和急性病的理想選擇,可以減少就診和住院的次數。此外,穿戴式科技、行動醫療應用和人工智慧 (AI) 驅動的診斷工具的持續創新正在提升各種自我護理醫療設備的功能。即時監測、數據分析和智慧型手機整合等功能的增強,使這些設備更加高效精準,吸引了精通技術的人。加之人們對預防保健和自我健康管理益處的認知不斷提高,這些因素共同推動了自我護理醫療設備的普及。隨著人們越來越重視自身健康,對兼具便利性、精準性和可靠性的設備的需求也日益成長。
由於糖尿病、高血壓和呼吸系統疾病等慢性病病例不斷增加,美國是該市場的重要區域。自我管理和治療設備使患者能夠有效管理自身健康,並減少對醫療機構的依賴。此外,數位健康平台的日益普及正在改變醫療保健管理方式,使預約、藥品配送和預防保健等服務觸手可及。這些平台提高了便利性,增強了病患參與度,並擴大了關鍵醫療資源的取得途徑。例如,輝瑞公司於2024年在美國推出了其數位健康平台「PfizerForAll」。該平台提供當日就診、藥品配送、疫苗接種預約以及輝瑞藥品經濟援助等服務。該平台旨在提高美國民眾醫療保健管理的效率和可近性。未來計劃進一步擴展,以滿足更多醫療保健需求。
人口老化加劇
人口老化加劇是推動醫療器材市場成長的主要因素,因為老年人罹患糖尿病、高血壓、心血管疾病和關節炎等慢性疾病的風險更高。根據聯合國估計,65歲及以上人口預計將從2021年的7.61億增加到2050年的16億,成長超過一倍。 80歲及以上人口的成長速度甚至更快。此外,由於預期壽命延長和家庭規模縮小等人口結構變化,即使在人口結構較年輕的國家,老化也是不可逆轉的全球現象。 2021年,全球每十個人中就有一人年齡在65歲或以上。預計到2050年,這一年齡層的人口將佔全球總人口的六分之一。因此,隨著人口老化,血糖值儀和血壓計等用於管理上述疾病的自我護理醫療設備的銷售量也隨之成長。
慢性病發生率呈上升趨勢
在全球範圍內,糖尿病和高血壓等慢性疾病的盛行率正在上升。糖尿病已成為個人、家庭和國家面臨的日益嚴峻的全球性挑戰。根據國際糖尿病聯盟(IDF)發布的《糖尿病地圖集》,全球20至79歲成年人中,10.5%患有糖尿病,其中近一半患者對此毫不知情。 IDF預測,到2045年,全球將有約7.83億成年人(八分之一)患有糖尿病,比目前的數字增加46%。 2型糖尿病佔糖尿病病例的90%以上,其發病受社會經濟、人口、環境和遺傳因素的影響。這推動了對能夠幫助患者在家中進行自我管理和監測的產品的需求。此外,由於持續血糖監測儀(CGM)和血壓監測儀在管理這些疾病方面的有效性,它們正變得越來越受歡迎。例如,CGM的廣泛應用得益於技術的進步和價格的下降。
技術進步
自我護理醫療設備市場的成長得益於人工智慧 (AI)、行動醫療應用和數位平台的快速融合,這些技術正在改變人們在傳統臨床環境之外監測和管理自身健康的方式。穿戴式科技和非侵入性血糖監測等技術的進步正在推動自我護理醫療設備在創新、精準度和功能性方面的提升。例如,2025 年,首爾大學工程學院機械工程係穿戴式軟性電子實驗室高承煥教授領導的研究團隊宣布開發出一種穿戴式電子設備,該設備像OK繃一樣貼附在皮膚上,能夠長時間即時連續監測血壓。目前,領先企業正在推出更先進的產品版本以滿足這些需求。例如,2024 年 3 月 18 日,強生醫療科技與英偉達 (NVIDIA) 合作,旨在提升人工智慧在外科手術中的應用能力。此次合作也旨在加速邊緣端的即時手術數據分析,從而提高手術效率和安全性。強生醫療科技公司也計劃推動人工智慧模型的開發和部署,從而實現與旗下數位化手術平台的可擴展整合。在此背景下,各公司不斷提交新產品註冊申請以保持競爭力,這也推動了市場成長。
The global self-care medical devices market size is anticipated to reach USD 27.5 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 45.0 Billion by 2034, exhibiting a CAGR of 5.65% from 2026-2034. North America currently dominates the market, holding a market share of over 34.7% in 2025. The growing geriatric population and rising chronic diseases like diabetes and hypertension are increasing demand for self-care medical devices. Technological advances, including AI-driven platforms, wearables, and non-invasive monitoring, further enhance device adoption and functionality. Companies are launching innovative products and partnerships to stay competitive, expanding the self-care medical devices market growth.
With healthcare expenses on the rise, self-care medical devices offer a cost-effective solution for patients. They reduce the need for frequent doctor visits and hospital stays, making them an attractive option for managing chronic and acute conditions. Moreover, continuous innovations in wearable technology, mobile health applications, and artificial intelligence (AI)-driven diagnostic tools are enhancing the functionality of various self-care medical devices. Enhanced features, such as real-time monitoring, data analysis, and integration with smartphones, are making these devices more efficient, accurate, and appealing to tech-savvy individuals. Apart from this, the growing awareness among people about the benefits of preventive healthcare and self-management of health conditions is driving the adoption of self-care medical devices. Individuals are more inclined to take control of their health, leading to higher demand for devices that offer convenience, accuracy, and reliability.
The United States is a key region in the market owing to the rising cases of chronic conditions such as diabetes, hypertension, and respiratory disorders among the masses, which self-monitoring and therapeutic devices. These devices empower patients to manage their health effectively and reduce dependence on healthcare facilities. Besides this, the growing adoption of digital health platforms is transforming healthcare management by offering seamless access to services, including appointments, medication delivery, and preventive care. These platforms increase convenience, boost patient involvement, and broaden access to vital healthcare resources. For instance, in 2024, Pfizer introduced PfizerForAll, a digital health platform in the US that provides services such as same-day healthcare appointments, medication delivery, vaccine reservations, and financial assistance for Pfizer medications. The platform seeks to streamline healthcare administration and enhance service accessibility for individuals in America. Future expansions are planned to include additional healthcare needs.
Rising Geriatric Population
The rise in the number of older individuals is acting as a major driver, as they have higher chances of acquiring long-term illnesses like diabetes, blood pressure, cardiovascular diseases, and arthritis. As per the United Nations (UN), the number of people 65 years and older will more than double, from 761 Million in 2021 to 1.6 Billion by the year 2050. The population 80 years and older is increasing at an even accelerated rate. In addition, aging population is an irreversible worldwide phenomenon fueled by the demographic transition of increased lifespans and reduced physical family size even among nations with young populations. In 2021, 1 out of 10 individuals globally was over the age of 65. The age group is estimated to account for 1 out of 6 individuals worldwide in 2050. Therefore, the increasing geriatric population is growing sales of self-care medical devices like blood glucose meters and blood pressure monitors that are vital in controlling these conditions.
Increasing Prevalence of Chronic Diseases
The global prevalence of chronic diseases like diabetes and hypertension is on the rise. Diabetes is a growing global challenge for people, households, and countries. 10.5% of the adult population aged 20-79 years worldwide has diabetes, and almost half of them are unaware of it, as per the International Diabetes Federation (IDF) Diabetes Atlas. IDF projections suggest that by 2045, there will be an estimated 783 Million adults, or 1 in 8, with diabetes, a 46% increase from today's number. Type 2 diabetes affects more than 90% of diabetes cases and is impacted by socio-economic, demographic, environmental, and genetic determinants. This generates demand for products that enable patients to self-monitor and control their condition in the home setting. In addition, continuous glucose monitors (CGMs) and blood pressure monitors are gaining traction because they are effective in controlling these conditions. For example, the penetration of CGMs has been supported by technology and growing affordability.
Technological Developments
The self-care medical devices market growth is being propelled by the rapid integration of artificial intelligence (AI), mobile health applications, and digital platforms that transform how individuals monitor and manage their health outside traditional clinical environments. The new innovations and precision and functionality of self-care medical devices are being enhanced by developments such as wearable technology and non-invasive glucose monitoring. For instance, in 2025, Seoul National University College of Engineering revealed that a research team headed by Professor Seung Hwan Ko from the Wearable Soft Electronics Lab in the Department of Mechanical Engineering has created a wearable electronic device that adheres to the skin like a bandage and allows for real-time, ongoing monitoring of blood pressure for prolonged durations. Currently, large companies are unveiling advanced product versions to meet these needs. For example, on 18 March 2024, Johnson & Johnson MedTech partnered with NVIDIA to boost AI abilities within surgical operations. This collaboration is also designed to speed up real-time surgical data analysis at the edge, making operations efficient and secure. Johnson & Johnson MedTech also intends to make it easier to develop and deploy AI models, enabling scalable integration in its digital surgery platform. As a result, firms are constantly applying for new product registrations to remain competitive, which is also driving market growth.
Self-monitoring of blood glucose (SMBG) stands as the largest component in 2025, holding 43.5% of the market share. Self-monitoring of blood glucose (SMBG) dominates the market, as it is crucial for diabetic patients to manage their blood sugar levels independently, driving significant demand globally. It typically includes glucose meters and continuous glucose monitoring systems (CGMs), offering convenience and real-time data for effective diabetes management. Additionally, the market for SMBG devices is characterized by ongoing technological advancements aimed at improving experience of the user, accuracy, and integration with digital health platforms. In February 2023, Afon Technology Ltd. announced on Twitter the introduction of a non-invasive blood glucose sensor, a wearable gadget launched in the beginning of 2024. It is entirely non-invasive and removes the necessity for needles or lancets, presenting a far more appealing choice for individuals managing diabetes. This segment is also fueled by the increasing prevalence of diabetes worldwide and the rising preference for home-based healthcare solutions, which is creating a positive self-care medical devices market outlook.
Geriatric accounts for the majority of the market share. Geriatric individuals aged 65 and above are driving the demand for self-care medical devices due to their increasing healthcare needs and desire for independent living. Moreover, the growing number of geriatric users often require devices for chronic disease management, mobility aids, and remote monitoring solutions to maintain health and quality of life. According to the World Health Organization (WHO) by 2030, one out of every six people worldwide will be 60 years of age or older. During this period, the population aged 60 years and above will rise from 1 Billion in 2020 to 1.4 Billion. By 2050, the global population of individuals aged 60 years and older is projected to double to 2.1 Billion. The number of people aged 80 years or older is expected to triple from 2020-2050, reaching 426 Million. Hence, manufacturers and healthcare providers are focusing on developing user-friendly, intuitive devices tailored to the needs and preferences of this demographic, thereby shaping the self-care medical devices market growth trajectory.
In 2025, pharmacies hold a notable market share of 42.5%. Pharmacies provide an easy way for consumers to obtain self-care tools like blood pressure monitors, glucose meters, and respiratory aids. Their existence in both urban and rural settings improves market reach, addressing various demographic requirements. Pharmacies gain from pharmacists' knowledge in suggesting appropriate devices, which enhances consumer trust and guarantees efficient self-care management, leading to an optimistic outlook for the self-care medical devices sector. According to the statistics from the Organization for Economic Cooperation and Development (OECD), between 2000 and 2019, the ratio of pharmacists to the population rose by almost 40% on average in OECD countries with accessible time series data, reaching 86 pharmacists for every 100,000 residents. Thus, this significance highlights pharmacies' vital function in delivering crucial medical equipment directly to individuals worldwide.
In 2025, North America accounted for the largest market share of 34.7%. North America primarily includes individual consumers seeking convenient healthcare options at home, driven by the aging population's desire for greater independence and control over their health. The market caters extensively to personal health monitoring devices, such as glucose monitors, blood pressure monitors, and wearable fitness trackers, which empower users to manage their health proactively and independently. According to an article published on 22 May 2024, researchers from the University of California San Diego have created a wearable ultrasound patch capable of continuously and non-invasively monitoring brain blood flow. This soft, flexible patch is worn on the temple, providing three-dimensional cerebral blood flow data, a pioneering achievement in wearable technology. The team, led by Professor Sheng Xu, disclosed their innovation in Nature. According to the self-care medical devices market forecast, the region is anticipated to experience significant growth in the coming years due to the increasing adoption of health-monitoring technologies and the rising demand for convenient at-home healthcare solutions.
United States Self-Care Medical Devices Market Analysis
The United States stands as one of the largest and most sophisticated market for self-care medical devices, characterized by exceptionally high healthcare expenditure exceeding three trillion dollars annually, advanced technological adoption across consumer segments, and increasingly comprehensive insurance coverage that now frequently reimburses remote patient monitoring solutions as cost-effective alternatives to traditional care delivery. The country faces a significant chronic disease burden, with conditions including diabetes, cardiovascular disease, chronic obstructive pulmonary disease, and sleep disorders affecting hundreds of millions of Americans and creating substantial ongoing demand for home monitoring equipment that enables condition management and complication prevention. The Centers for Medicare and Medicaid Services has strategically expanded reimbursement codes for remote patient monitoring services, creating financial incentives for both healthcare providers and patients to adopt self-care technologies as standard components of chronic disease management programs. Digital health platforms are proliferating rapidly, offering integrated services that combine device data collection with telehealth video consultations, electronic prescription management, medication adherence tracking, and personalized wellness coaching delivered through mobile applications. Regulatory support through Food and Drug Administration initiatives specifically focused on home-use devices and artificial intelligence-enabled diagnostics accelerates innovation cycles while maintaining rigorous safety standards through risk-based classification systems and post-market surveillance requirements. In December 2024, the Food and Drug Administration released final recommendations for streamlining the approval process for medical devices that use artificial intelligence, with the guidance recommending information to include in predetermined change control plans as part of marketing submissions for artificial intelligence-enabled medical devices, facilitating faster deployment of advanced self-care technologies while maintaining appropriate regulatory oversight and patient safety protections.
Europe Self-Care Medical Devices Market Analysis
Europe's self-care medical devices sector is distinguished by stringent regulatory standards that prioritize patient safety, strong governmental emphasis on health technology assessment, and accelerating adoption of digital health solutions supported by comprehensive national eHealth strategies. The European Union's Medical Device Regulation provides extensive oversight encompassing device lifecycle management, clinical evidence requirements, post-market surveillance obligations, and unique device identification, while simultaneously accommodating technological innovation through adaptive frameworks that recognize the dynamic nature of software-driven medical devices. The aging population across European nations, with many countries experiencing median ages above forty-five years, drives substantial demand for home-based monitoring solutions that enable independent living, reduce caregiver burden, and decrease healthcare system strain from chronic condition management. Countries are implementing ambitious national digital health strategies that integrate self-care devices into broader healthcare ecosystems with particular emphasis on interoperability standards ensuring device data flows seamlessly into electronic health records, and data protection compliance with the General Data Protection Regulation requirements for sensitive health information. The European Health Data Space initiative, agreed upon through landmark negotiations in March 2024, is revolutionizing healthcare delivery by granting individuals unprecedented access to their electronic health data while facilitating secure cross-border health data exchange, supporting the integration of self-care device data into comprehensive longitudinal health records that inform clinical decision-making. Throughout 2024 and into 2025, the European Commission has been actively updating medical device regulations, including the implementation of unique device identifier systems that enable device tracking throughout the supply chain, expert panel designations providing specialized scientific guidance, and enhanced guidance documents on software classification.
Asia Pacific Self-Care Medical Devices Market Analysis
The Asia Pacific region represents the fastest-growing geographic market for self-care medical devices globally, driven by enormous populations exceeding four billion people, rapidly rising disposable incomes particularly among expanding middle classes, increasing health awareness through public education campaigns, and substantial government initiatives to strengthen healthcare infrastructure and achieve universal health coverage goals. Countries including China, India, Japan, South Korea, and Southeast Asian nations are experiencing rapid adoption of digital health technologies and home-based medical devices as components of healthcare system modernization strategies. The region faces significant chronic disease burden with diabetes, cardiovascular disease, and respiratory conditions affecting hundreds of millions of individuals, combined with persistent healthcare access challenges particularly in rural and remote areas where clinical facilities remain limited, making self-care solutions particularly valuable for extending medical services to underserved populations and reducing geographic health disparities. Governments are implementing ambitious policies to encourage medical technology innovation through research funding, tax incentives, regulatory streamlining, and support for local manufacturing capabilities to reduce import dependence and create domestic medical device industries. Regional healthcare systems are increasingly incorporating remote monitoring platforms and telehealth consultation services, creating integrated digital ecosystems for self-care device deployment that connect patients, devices, and healthcare providers. In September 2024, Medtronic inaugurated Southeast Asia's first Robotics Experience Studio in Singapore, a state-of-the-art facility that focuses on skill-building in robotic-assisted procedures and artificial intelligence applications, supporting the region's rising demand for precision care and medical technology while strengthening the regional healthcare ecosystem by fostering collaboration between industry, academia, and healthcare providers, providing hands-on training for healthcare professionals, and facilitating access to cutting-edge technologies that improve patient outcomes across Southeast Asia.
Latin America Self-Care Medical Devices Market Analysis
Latin America is embracing self-care medical device technology with growing recognition of its potential to address persistent healthcare accessibility challenges and reduce strain on overburdened public health systems that struggle to meet population needs with limited budgets and resources. The region's healthcare infrastructure varies significantly between countries and within countries, with urban areas generally possessing better access to advanced medical technologies, specialist physicians, and diagnostic facilities compared to rural regions where basic healthcare services remain limited. Economic factors substantially influence adoption patterns, with price-sensitive markets driving particular demand for cost-effective self-monitoring solutions that provide value without premium pricing, while import tariffs and currency fluctuations affect device affordability and market dynamics. Governments are gradually implementing regulatory frameworks that balance essential safety requirements with pragmatic recognition of the need to improve healthcare access, with some countries establishing expedited approval pathways for devices already approved in reference markets.
Middle East and Africa Self-Care Medical Devices Market Analysis
The Middle East and Africa region is experiencing gradual but steady adoption of self-care medical devices, driven by ongoing healthcare infrastructure development, increasing chronic disease prevalence particularly in urban populations, and government initiatives to modernize health systems as components of broader economic development strategies. Gulf Cooperation Council countries including the United Arab Emirates, Saudi Arabia, and Qatar are investing heavily in healthcare technology as central elements of economic diversification strategies that reduce oil dependence and position these nations as regional healthcare hubs. African nations are exploring self-care solutions to extend medical services to remote populations with severely limited clinical access, recognizing that traditional healthcare delivery models cannot economically reach dispersed rural populations.
Major participants in the market are diligently concentrating on improving product innovation, broadening their digital health platforms, and reinforcing their distribution channels. They are putting resources into research and development to launch sophisticated, easy-to-use devices that offer enhanced accuracy and connectivity capabilities. Strategic alliances and collaborations are being emphasized to incorporate artificial intelligence and data analytics for customized healthcare solutions. Businesses are also broadening their market presence by focusing on emerging areas and modifying their products to cater to various consumer demands. Initiatives aimed at meeting regulatory standards and improving affordability are shaping their competitive approaches. In 2024, Oxymed introduced the SleepEasy Auto CPAP devices in India, which include advanced FlowSens algorithms, CSA detection, and adjustable therapy modes for improved sleep apnea treatment. These CE-certified products merge cost-effectiveness with global standards, highlighting Oxymed's growth in the respiratory care sector.